Decrease of apolipoprotein-A1 by gender and age in US cohort. by Thierry Poynard (38084)

Loss of SID-1 and/or SID-3 functionality decreases DA neurodegeneration and improves DA neuron function. by Anthony L. Gaeta (13272609)

Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.docx by Chantal C. Clark (10684632)

“…</p><p>Conclusion: We observed an association between the use of preexisting thromboprophylaxis and a decreased risk of TE during COVID-19. This suggests that these therapies are beneficial for coping with COVID-19 associated hypercoagulability. …”

Data Sheet 1_Decreased cigarette smoking may partially explain the increased prevalence of antinuclear antibodies in the United States.pdf by Gregg E. Dinse (4500940)

“…High-titer antinuclear antibodies (ANA) are associated with autoimmune diseases, and ANA prevalence in the US increased between 1988 and 2012. Tobacco smoking decreased during those years while vaping of electronic cigarettes (e-cigarettes) increased after their introduction in 2007. …”

Viral replication in obese mice results in decreased genetic diversity. by James Weger-Lucarelli (603766)

Additional file 12 of Decreased complement 4 and interleukin-10 as biomarkers in aqueous humour for non-exudative age-related macular degeneration: a case control study by Juliane Schikora (20871169)

Depletion of EphA3 or EphA4 recovers the decreased ERK and Akt activation and lytic gene expression in RNF5 KO PEL cells. by Xiaojuan Li (351842)

Adjusted odds ratios of facilities serving as COVID-19 vaccine administration locations, interaction for proportion non-Hispanic Black population and urbanicity. by Inmaculada Hernandez (8833814)

Fig 4 - by Rafael Alves Guimarães (4526788)

Fig 3 - by Rafael Alves Guimarães (4526788)

PCR amplification of <i>bla</i>_OXA-51 like gene in some <i>A</i>. <i>baumannii</i> clinical isolates, lane M, a gene ruler 100 bp ladder; lane 1, a positive control; lan... by Mostafa A. Mohammed (9306115)

Phenotypic analysis of the recovered <i>A</i>. <i>baumannii</i> isolates (n = 100). by Mostafa A. Mohammed (9306115)

Antimicrobial susceptibility testing of <i>A</i>. <i>baumannii</i> isolates (n = 100). by Mostafa A. Mohammed (9306115)

Frequencies of <i>A</i>. <i>baumannii</i> isolates from patients with different clinical samples. by Mostafa A. Mohammed (9306115)

Antimicrobial agents resistance profiles scored for different <i>A</i>. <i>baumannii</i> isolates. by Mostafa A. Mohammed (9306115)

ERIC-PCR dendrogram analysis for 34 <i>A</i>. <i>baumanni</i> was constructed by the UPGMA clustering method. by Mostafa A. Mohammed (9306115)

COVID-19 incidence increases over time with a decreased importance of genetic COVID-19 susceptibility. by C. A. Robert Warmerdam (12568808)

“…The error bars represent the 95% confidence interval for the regression coefficients. The plot shows a decrease in the variance explained by the PGS during the COVID-19 pandemic.…”

Cell-autonomous and non-cell autonomous effects of neuronal BIN1 loss <i>in vivo</i> by Kathleen M. McAvoy (7224863)

“…Taken together, our data suggest that the contribution of genetic variation in BIN1 locus to AD risk could result from a cell-autonomous reduction of neuronal excitability due to Bin1 decrease, exacerbated by the presence of aggregated Tau, coupled with a non-cell autonomous microglia activation.…”

Image1_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF by Gabriella Gálffy (177759)

“…The COVID-19 pandemic resulted in a statistically significant decrease in lung cancer incidence, especially in the 50–59 age group (both sexes).…”

Image2_Decreasing incidence and mortality of lung cancer in Hungary between 2011 and 2021 revealed by robust estimates reconciling multiple data sources.TIFF by Gabriella Gálffy (177759)

“…The COVID-19 pandemic resulted in a statistically significant decrease in lung cancer incidence, especially in the 50–59 age group (both sexes).…”